The PTTG1/AURKA Axis Drives Acquired Anlotinib Resistance in Non-Small Cell Lung Cancer by Remodeling the Tumor Immune Microenvironment.

Hui K, Tan Y, Song J, Hu C, Wu S, Sun W, Song L, Jiang X

Open source

DOI
10.1002/biof.70153
Published
2026 Sep-Oct
Container
BioFactors (Oxford, England)
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/biof.70153,
  title = {The PTTG1/AURKA Axis Drives Acquired Anlotinib Resistance in Non-Small Cell Lung Cancer by Remodeling the Tumor Immune Microenvironment.},
  author = {Hui K and Tan Y and Song J and Hu C and Wu S and Sun W and Song L and Jiang X},
  year = {2026},
  journal = {BioFactors (Oxford, England)},
  doi = {10.1002/biof.70153},
  url = {https://doi.org/10.1002/biof.70153}
}

RIS

TY  - JOUR
TI  - The PTTG1/AURKA Axis Drives Acquired Anlotinib Resistance in Non-Small Cell Lung Cancer by Remodeling the Tumor Immune Microenvironment.
AU  - Hui K
AU  - Tan Y
AU  - Song J
AU  - Hu C
AU  - Wu S
AU  - Sun W
AU  - Song L
AU  - Jiang X
PY  - 2026
JO  - BioFactors (Oxford, England)
DO  - 10.1002/biof.70153
UR  - https://doi.org/10.1002/biof.70153
ER  - 

APA

K, H., Y, T., J, S., C, H., S, W., W, S., L, S., & X, J. (2026). The PTTG1/AURKA Axis Drives Acquired Anlotinib Resistance in Non-Small Cell Lung Cancer by Remodeling the Tumor Immune Microenvironment.. BioFactors (Oxford, England). https://doi.org/10.1002/biof.70153

Source records